BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 9.45% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 9.24% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 8.84% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 6.30% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.79% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 4.70% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.47% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.45% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.96% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.60% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.55% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 3.52% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 3.13% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 2.89% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 2.66% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 2.42% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.24% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 2.15% |
| ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 2.05% |
| BFLY | Butterfly Network Inc | Healthcare | Medical Devices | 1.93% |